Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Adiposs logo — Imaging Body Fat - Saving Lives

Adiposs

Imaging Body Fat - Saving Lives

Founded 2020 Switzerland Geneva, Switzerland 6 employees Convertible Note Total: $2.15M Biotechnology

General Information

Company Name Adiposs
Founded Year 2020
Location Switzerland Geneva, Switzerland +1
Employees 6
Industries Biotechnology
Funding Stage Convertible Note
Social

Get notified when Adiposs moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Adiposs

Adiposs is a Swiss biotechnology startup, founded in 2020, committed to developing ImageBAT, the first and only medical imaging product for brown fat, with a slogan of "Imaging Body Fat - Saving Lives". The technology has promising applications in multiple indications, particularly in cancer and obesity. The company's go-to-market strategy is focused on oncology, as the ImageBAT scan has demonstrated the ability to predict the response to cancer immunotherapy, which is emerging as the gold standard in cancer treatment. Adiposs has successfully completed a phase 1 human clinical trial and is now poised to advance to phase II clinical development in the field of oncology. In the most recent funding round at 24 December 2021, Adiposs secured a Fr.1.80M Seed Round investment from a consortium of prominent investors including Privilège Ventures, Venture Kick, Clinical Research Ventures, FONGIT, and Kingbridge. The company's headquarters is located in Switzerland. The focus on leveraging medical imaging for innovative applications, particularly in the context of emerging cancer therapies, positions Adiposs as a compelling player in the biotechnology space. The recent seed round investment underscores the confidence of notable venture capital firms in Adiposs' potential to drive impactful advancements in both diagnostics and treatment within the oncology and obesity fields.

Taxonomy: Medical Imaging, Clinical-stage Company, Cancer Immunotherapy, Oncology, Biomarker Development, Brown Fat Imaging, Human Clinical Trials, Swiss Life Science, MedTech, Phase II Clinical Development, Cancer Therapy, ImageBAT, Immuno-oncology, Predictive Imaging

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 1
Investor
12 Apr 2024
Seed Round •••••• 5
Investor Investor Investor Investor
•••• •••• 		24 Dec 2021
Convertible Note •••••• 1 •••• •••• 03 Jun 2021
Non Equity Assistance •••••• 1
Investor
21 Oct 2020
Debt Financing •••••• 1 •••• •••• 11 Aug 2020

View All 8 Funding Rounds

Adiposs Alternatives & Competitors

Adiposs vs
Apexigen
Apexigen United States

Creating Transformative Immunotherapies for Patients with Cancer

Post Ipo Equity
11 employees
Biopharma, Biotechnology
Adiposs vs
Aurora Oncology
Aurora Oncology

Pioneering targeted therapeutics to combat non-muscle invasive bladder cancer with precision.

Grant
Biotechnology, Health Care
Adiposs vs
Splash Pharmaceuticals
Splash Pharmaceuticals United States

Splash Pharmaceuticals is a privately held clinical stage oncology pharmaceutical company advancing...

Series D
1 employees
Biotechnology, Pharmaceutical

FAQ About Adiposs

Imaging Body Fat - Saving Lives
Adiposs was founded in 2020.
Adiposs is headquartered in Geneva, Switzerland.
Adiposs operates in the following industries: Biotechnology.
Adiposs has approximately 6 employees.
Adiposs has completed 8 funding rounds, raising a total of $2.15M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Adiposs include Apexigen, Aurora Oncology, Splash Pharmaceuticals, Cumulus Oncology, Rexahn Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Adiposs and Apexigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Adiposs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy